Is serum viscosity a new prognostic factor in non-Hodgkin lyphoma's patients?

被引:0
|
作者
Utkan, Gungor
Tek, Ibrahim
Kocer, Murat
Tokluoglu, Saadet
Muallaoglu, Sadik
Arslan, Ulku Y.
Celenkoglu, Gokhan
Durnali, Ayse G.
Alkis, Necati
机构
[1] Ankara Oncol Training & Res Hosp, Ankara, Turkey
[2] Ankara Univ, Sch Med, TR-06100 Ankara, Turkey
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:209 / 209
页数:1
相关论文
共 50 条
  • [41] Chop chemotherapy in non-Hodgkin's lymphoma: Prognostic factors in 123 patients
    Pedro, C
    Besses, C
    Paez, A
    Acin, P
    Monzo, S
    Asensio, A
    SansSabrafen, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1376 - 1376
  • [42] Prognostic value of cytogenetic abnormalities in patients with non-Hodgkin's lymphoma.
    Juneja, S
    Matthews, J
    Lukeis, R
    Laidlaw, C
    Cooper, I
    Wolf, M
    Ironside, P
    Garson, OM
    BLOOD, 1995, 86 (10) : 2115 - 2115
  • [43] Prognostic factors in Hodgkin and non-Hodgkin lymphomas
    Cuenca, X.
    Xhaard, A.
    Mounier, N.
    BULLETIN DU CANCER, 2009, 96 (04) : 461 - 473
  • [44] Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma
    Niitsu, N
    Okabe-Kado, J
    Okamoto, M
    Takagi, T
    Yoshida, T
    Aoki, S
    Hirano, M
    Honma, Y
    BLOOD, 2001, 97 (05) : 1202 - 1210
  • [45] Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma
    Kok, M
    Bonfrer, JM
    Korse, CM
    de Jong, D
    Kersten, MJ
    TUMOR BIOLOGY, 2003, 24 (01) : 53 - 60
  • [46] Prognostic significance of serum Beta 2 Microglobulin in Non-Hodgkin Lymphoma
    Gupta, G.
    Ghalaut, V. S.
    Lokanathan, V.
    Sharma, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [47] The Prognostic Significance of Elevated Levels of Serum Ferritin Before Chemotherapy in Patients With Non-Hodgkin Lymphoma
    Yoh, Kyung Ah
    Lee, Ho Sup
    Park, Lee Chun
    Lee, Eun Mi
    Shin, Seong Hoon
    Park, Dae Jin
    Ye, Byeong Jin
    Kim, Yang Soo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01): : 43 - 49
  • [48] Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma
    Bairey, O
    Blickstein, D
    Monselise, Y
    Lahav, J
    Stark, P
    Prokocimer, M
    Nativ, HM
    Kirgner, I
    Pazgal, I
    Shaklai, M
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (05) : 384 - 391
  • [49] New drugs in non-Hodgkin's lymphoma
    Arbuck, SG
    Sorensen, JM
    Christian, MC
    Ho, P
    Pluda, JM
    Cheson, BD
    ANNALS OF ONCOLOGY, 1997, 8 : 119 - 128
  • [50] A new approach to non-Hodgkin's lymphoma
    Hauke, RJ
    Armitage, JO
    INTERNAL MEDICINE, 2000, 39 (03) : 197 - 208